Condition
Mycobacterium Tuberculosis clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Mycobacterium Tuberculosis clinical trials that are recruiting, at sites in 11 countries (most in Kenya (1), India (1), Indonesia (1)). 1 was first registered in the last 30 days. By phase: Phase 3 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 11Countries
Newest Mycobacterium Tuberculosis clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Biomarker Test for Diagnosis and Monitoring of Extrapulmonary Tuberculosis | — | Nairobi and 1 other locations | Recruiting | Oct 28, 2026 |
| New six-month regimen for MDR-TB in France using BPaLM or BPaLC/BPaLM+Clofazimine | Phase 3 | Amiens and 4 other locations | Recruiting | Mar 20, 2026 |
| Blood TB DNA test to track treatment progress | — | Tak | Recruiting | Feb 25, 2025 |
| Shortened treatment for tuberculosis in children | Phase 3 | Chennai and 8 other locations | Recruiting | Feb 12, 2024 |
| Improving tuberculosis diagnosis in Swiss children | — | Aarau and 7 other locations | Recruiting | Feb 7, 2017 |
All recruiting trials (5)
-
Biomarker Test for Diagnosis and Monitoring of Extrapulmonary Tuberculosis
This study tests biomarker-based methods to help diagnose extrapulmonary TB and monitor treatment in adults, including people living with HIV, using samples from affected sites in Kenya.
-
New six-month regimen for MDR-TB in France using BPaLM or BPaLC/BPaLM+Clofazimine
This trial tests whether a six-month, bedaquiline-containing treatment strategy for rifampicin-resistant TB works as well as the long traditional regimens used in France by comparing outcomes to a historical cohort.
-
Blood TB DNA test to track treatment progress
This project will test whether levels of TB-derived cell-free DNA in the blood can track treatment response in adults newly diagnosed with tuberculosis.
-
Shortened treatment for tuberculosis in children
This study is testing if a shorter 2-month treatment for tuberculosis works just as well and is safe for children under 10 as the usual 4- to 6-month treatment.
-
Improving tuberculosis diagnosis in Swiss children
This study is testing new blood tests to see if they can better diagnose tuberculosis in children compared to current methods.
Related topics
Quick answers
How many Mycobacterium Tuberculosis clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in Kenya (1 trial), India (1 trial), Indonesia (1 trial), Mozambique (1 trial), South Africa (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.